Article Type
Changed
Thu, 12/15/2022 - 18:02

Editor Jame Abraham argues that once there is appropriate clinical trial infrastructure, there is only one person who can increase the clinical trial accrual: the treating oncologist.

 

Click on the PDF icon at the top of this introduction to read the full article.

Article PDF
Issue
The Journal of Community and Supportive Oncology - 13(10)
Publications
Topics
Page Number
341
Legacy Keywords
breast cancer, clinical trials, NSABP B-31, clinical trial accrual, ER/PR-positive, HER2-positive
Sections
Article PDF
Article PDF

Editor Jame Abraham argues that once there is appropriate clinical trial infrastructure, there is only one person who can increase the clinical trial accrual: the treating oncologist.

 

Click on the PDF icon at the top of this introduction to read the full article.

Editor Jame Abraham argues that once there is appropriate clinical trial infrastructure, there is only one person who can increase the clinical trial accrual: the treating oncologist.

 

Click on the PDF icon at the top of this introduction to read the full article.

Issue
The Journal of Community and Supportive Oncology - 13(10)
Issue
The Journal of Community and Supportive Oncology - 13(10)
Page Number
341
Page Number
341
Publications
Publications
Topics
Article Type
Legacy Keywords
breast cancer, clinical trials, NSABP B-31, clinical trial accrual, ER/PR-positive, HER2-positive
Legacy Keywords
breast cancer, clinical trials, NSABP B-31, clinical trial accrual, ER/PR-positive, HER2-positive
Sections
Citation Override
JCSO 2015;13(10):341
Disallow All Ads
Alternative CME
Article PDF Media